We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Genepoint Biological Technology Stock

Invest in or calculate the value of your shares in Genepoint Biological Technology or other pre-IPO companies through EquityZen's platform.

Get Started

Genepoint Biological Technology Stock

Genepoint Biological Technology is a healthcare technology company that offers application and process control services.

About Genepoint Biological Technology Stock

Founded

2015

Industries

Software, Data and Analytics, Artificial Intelligence

Genepoint Biological Technology is an innovative technology that focuses on the initiatives, technology application, and process control of cryogenic biomaterials, which includes the generation of a cryogenic cell storage automation system and the total solution of alternative energy options. They are dedicated to advancing IoT, automation, and intelligence technology and investigating novel cryogenic biomaterial system operating paradigms. They provide the following products: Hatch TM, Pelican, Hatch-Lite, Flexible Robot for Biobank, and Kiosk.

Genepoint Biological Technology Management

Leadership team at Genepoint Biological Technology

Chief Executive Officer & Founder

Zhehua Chen

Locked Features

Join now and verify your accreditation status to gain access to:

  • Genepoint Biological Technology current valuation
  • Genepoint Biological Technology stock price
  • Available deals in Genepoint Biological Technology and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Genepoint Biological Technology stock?

Accredited investors can buy pre-IPO stock in companies like Genepoint Biological Technology through EquityZen funds. These investments are made available by existing Genepoint Biological Technology shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Genepoint Biological Technology stock?

Shareholders can sell their Genepoint Biological Technology stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."